Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines

被引:7
|
作者
Essogmo, Freddy Elad [1 ,2 ]
Zhilenkova, Angelina V. [1 ]
Tchawe, Yvan Sinclair Ngaha [1 ]
Owoicho, Abah Moses [1 ]
Rusanov, Alexander S. [1 ]
Boroda, Alexander [1 ]
Pirogova, Yuliya N. [1 ]
Sangadzhieva, Zaiana D. [1 ]
Sanikovich, Varvara D. [1 ]
Bagmet, Nikolay N. [3 ]
Sekacheva, Marina I. [1 ]
机构
[1] Sechenov Univ, Moscow State Med Univ 1, Inst Personalized Oncol, Ctr Digital Biodesign & Personalized Healthcare,Mi, Moscow 119991, Russia
[2] Cameroon Oncol Ctr COC, POB 1864, Douala, Cameroon
[3] Petrovsky Natl Res Ctr Surg, Moscow 119435, Russia
关键词
lung cancer; cytokines; therapy; immune system; anti-tumor; TGF-BETA; IMMUNOTHERAPY; ROLES; INTERLEUKIN-10; INFLAMMATION; IMMUNITY; BIOLOGY; CELLS;
D O I
10.3390/cancers15225383
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Lung cancer is currently the second leading cause of cancer death worldwide. Cytokines are small proteins that carry messages between cells and are known to play an important role in the body's response to inflammation and infection. Cytokines are important for immunity in lung cancer. The immune system relies heavily on cytokines which can also be produced in the laboratory for therapeutic use. Cytokine therapy helps the immune system to stop the growth or kill cancer cells including lung cancer cells. High doses of cytokines are required to induce a beneficial response in cancer patients, but doing so leads to many problems, including their short lifespan and toxicity. New technologies are being developed to help improve the targeting of cytokines and alter their side effects.Abstract Lung cancer is currently the second leading cause of cancer death worldwide. In recent years, checkpoint inhibitor immunotherapy (ICI) has emerged as a new treatment. A better understanding of the tumor microenvironment (TMJ) or the immune system surrounding the tumor is needed. Cytokines are small proteins that carry messages between cells and are known to play an important role in the body's response to inflammation and infection. Cytokines are important for immunity in lung cancer. They promote tumor growth (oncogenic cytokines) or inhibit tumor growth (anti-tumour cytokines) by controlling signaling pathways for growth, proliferation, metastasis, and apoptosis. The immune system relies heavily on cytokines. They can also be produced in the laboratory for therapeutic use. Cytokine therapy helps the immune system to stop the growth or kill cancer cells. Interleukins and interferons are the two types of cytokines used to treat cancer. This article begins by addressing the role of the TMJ and its components in lung cancer. This review also highlights the functions of various cytokines such as interleukins (IL), transforming growth factor (TGF), and tumor necrosis factor (TNF).
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Anti-tumor activities of probiotics in cervical cancer
    Moghaddaseh Jahanshahi
    Parisa Maleki Dana
    Bita Badehnoosh
    Zatollah Asemi
    Jamal Hallajzadeh
    Mohammad Ali Mansournia
    Bahman Yousefi
    Bahram Moazzami
    Shahla Chaichian
    Journal of Ovarian Research, 13
  • [42] XENOGENEIC ANTI-TUMOR ANTIBODIES IN CANCER RADIOIMMUNODETECTION
    GOLDENBERG, DM
    DELAND, FH
    KIM, EE
    PRIMUS, FJ
    TRANSPLANTATION PROCEEDINGS, 1980, 12 (01) : 188 - 191
  • [43] Anti-tumor activities of probiotics in cervical cancer
    Jahanshahi, Moghaddaseh
    Dana, Parisa Maleki
    Badehnoosh, Bita
    Asemi, Zatollah
    Hallajzadeh, Jamal
    Mansournia, Mohammad Ali
    Yousefi, Bahman
    Moazzami, Bahram
    Chaichian, Shahla
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [44] Anti-tumor mechanisms of rigosertib in colorectal cancer
    Mehr, S. M. Hassanian
    Rahmani, F.
    Hashemzehi, M.
    Avan, A.
    Barneh, F.
    Asgharzadeh, F.
    Moradi-Marjaneh, R.
    Soleimani, A.
    Parizadeh, M.
    Ferns, G. A.
    Mobarhan, M. Ghayour
    Ryzhikov, M.
    Afshari, A. R.
    Ahmadian, M. R.
    Giovannetti, E.
    Jafari, M.
    Rezaei, A. R.
    Khazaei, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S441 - S441
  • [45] Immunological efficacy of anti-tumor dendritic cell vaccine application in patients with non-small cell lung cancer
    Gorbach, O.
    Khranovska, N.
    Skachkova, O.
    Inomistova, M.
    Sovenko, V.
    Ganul, A.
    Orel, V.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S37 - S38
  • [46] Impact of saffron as an anti-cancer and anti-tumor herb
    Chermahini, Siavash Hosseinpour
    Majid, Fadzilah Adibah Abd
    Sarmidi, Mohamad Roji
    Taghizadeh, Ehsan
    Salehnezhad, Saleh
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 4 (11): : 834 - 840
  • [47] Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation
    Cao, Dai
    Chen, Die
    Xia, Jiang-Nan
    Wang, Wen-Yan
    Zhu, Guo-Yuan
    Chen, Li-Wen
    Zhang, Chuantao
    Tan, Bo
    Li, Hui
    Li, Ying-Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
  • [48] ANTI-TUMOR IMMUNITY IN BREAST-CANCER PATIENTS - BIOLOGIC AND THERAPEUTIC IMPLICATIONS
    BLACK, MM
    ZACHRAU, RE
    JOURNAL OF REPRODUCTIVE MEDICINE, 1979, 23 (01) : 21 - 32
  • [49] Exosomes in the ascites of ovarian cancer patients: Origin and effects on anti-tumor immunity
    Peng, Peng
    Yan, You
    Keng, Shen
    ONCOLOGY REPORTS, 2011, 25 (03) : 749 - 762
  • [50] Inflammatory Profile and Response to Anti-Tumor Necrosis Factor Therapy in Patients with Chronic Pulmonary Sarcoidosis
    Loza, Matthew J.
    Brodmerkel, Carrie
    Du Bois, Roland M.
    Judson, Marc A.
    Costabel, Ulrich
    Drent, Marjolein
    Kavuru, Mani
    Flavin, Susan
    Lo, Kim Hung
    Barnathan, Elliot S.
    Baughman, Robert P.
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (06) : 931 - 939